Sally Han

Internal and Government Investigation Matters

• Successfully resolved allegations of complex securities fraud brought by the U.S. Securities and Exchange Commission (SEC) against a China-based education company.
• Represented a China-based agricultural company in an investigation brought by the U.S. Securities and Exchange Commission (SEC) relating to accounting fraud issues.
• Conducted FCPA internal investigations for a leading global pharmaceutical company relating to its China business during a period in which the company was under a DOJ/SEC self-reporting obligation.
• Conducted internal investigations and advised compliance issues for numerous companies in multiple industries, including pharmaceutical, medical device, telecommunication, automotive, and construction.
• Advised pharmaceutical and medical device companies with regard to responding to Chinese government investigations, including by the Administration of Industry and Commerce, concerning allegations of commercial or public corruption.

Litigation

• Advised a leading Chinese solar panel manufacturer in defending a high-profile anti-trust lawsuit in the U.S.
• Represented a global agricultural company in a multi-billion dollar cross-border litigation alleging damages related to the commercialization of a genetically modified trait in the U.S. before receiving approval from Chinese authorities.
• Represented a global retail company and certain individual defendants in a purported class action litigation in federal court in Delaware arising out of the tender offer.
• Representing a U.S.-listed Chinese insurance company and certain of its directors and officers in a purported federal securities fraud class action in federal court in New York.
• Representing directors of a global entertainment company in stockholder class action in Delaware Chancery Court arising out of acquisition.
• Representing a major Chinese tire manufacturer in numerous product liability cases in multiple jurisdictions in the U.S.